Johansson, Hanna Katarina LilithSvingen, TerjeBoberg, JulieFowler , Paul AStead, DavidVinggaard, Anne MarieFilis, Panagiotis2020-05-202020-05-202020-04Johansson, H K L, Svingen, T, Boberg, J, Fowler , P A, Stead, D, Vinggaard, A M & Filis, P 2020, 'Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat', Archives of Toxicology, vol. 94, pp. 1241-1250. https://doi.org/10.1007/s00204-020-02697-30340-5761SCOPUS: 85082429722ORCID: /0000-0001-9268-5868/work/76974325ORCID: /0000-0002-4831-9075/work/79059739https://hdl.handle.net/2164/14335Open Access via Springer Compact Acknowledgements This work was funded by the Ministry of Environment and Food of Denmark, and by a grant from the European Commission 7th Framework Program CONTAMED (Contaminant mixtures and human reproductive health-novel strategies for health impact and risk assessment of endocrine disrupters, grant agreement no.: 215202), as well as the Medical Research Council (UK) (MR/L010011/1 to PAF) and the EU Horizon 2020 project FREIA (Grant Number 825100). We would like to thank Heidi Letting, the Animal facilities at DTU food, and the University of Aberdeen Proteomics Core Facility for their support and assistance in this work.101525248engovaryproteomeendocrine disruptionovarian dysgenesis syndromeAOPR MedicineHealth, Toxicology and MutagenesisToxicologyMedical Research Council (MRC)MR/L010011/1European Commission215202825100Supplementary DataRCalretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the ratJournal article10.1007/s00204-020-02697-3http://www.scopus.com/inward/record.url?scp=85082429722&partnerID=8YFLogxK94